NDC 66794-229
Rocuronium
Rocuronium
Rocuronium is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Piramal Critical Care Inc. The primary component is Rocuronium Bromide.
| Product ID | 66794-229_98255b70-51fa-8d16-e053-2995a90a8f97 |
| NDC | 66794-229 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Rocuronium |
| Generic Name | Rocuronium |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-06-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA210437 |
| Labeler Name | Piramal Critical Care Inc |
| Substance Name | ROCURONIUM BROMIDE |
| Active Ingredient Strength | 100 mg/10mL |
| Pharm Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |